Kuros Biosciences AG
General ticker "CSBTF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $802.5M (TTM average)
Kuros Biosciences AG follows the US Stock Market performance with the rate: 35.8%.
Estimated limits based on current volatility of 0.9%: low 38.33$, high 39.02$
Short-term CSBTF quotes
Long-term CSBTF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CHF17.99MM | CHF33.56MM | CHF75.56MM |
| Operating Expenses | CHF31.43MM | CHF46.76MM | CHF80.55MM |
| Operating Income | CHF-13.45MM | CHF-13.19MM | CHF-5.00MM |
| Non-Operating Income | CHF-2.54MM | CHF3.42MM | CHF1.65MM |
| Interest Expense | CHF4.32MM | CHF1.75MM | CHF0.15MM |
| R&D Expense | CHF5.19MM | CHF5.60MM | CHF6.98MM |
| Income(Loss) | CHF-15.99MM | CHF-9.78MM | CHF-3.35MM |
| Taxes | CHF0.00MM | CHF0.38MM | CHF0.37MM |
| Profit(Loss)* | CHF-14.60MM | CHF-13.73MM | CHF-3.51MM |
| Stockholders Equity | CHF68.86MM | CHF56.71MM | CHF58.75MM |
| Inventory | CHF3.17MM | CHF4.86MM | CHF9.44MM |
| Assets | CHF82.95MM | CHF71.46MM | CHF84.54MM |
| Operating Cash Flow | CHF-7.35MM | CHF-8.84MM | CHF3.14MM |
| Capital expenditure | CHF0.40MM | CHF0.33MM | CHF1.11MM |
| Investing Cash Flow | CHF-0.40MM | CHF-0.33MM | CHF-1.11MM |
| Financing Cash Flow | CHF3.22MM | CHF-0.17MM | CHF1.34MM |
| Earnings Per Share** | CHF-0.43 | CHF-0.38 | CHF-0.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.